JPRN-UMIN000003229已完成1 期
Phase I study of peptide vaccination for patients with unresectable biliary tract cancer - Phase I study of peptide vaccination for patients with unresectable biliary tract cancer
Tokyo Women's Medical University0 个研究点目标入组 9 人开始时间: 2010年2月23日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 9
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Pregnancy or lactation 2.Decision of unsuitableness by principal investigator 3.Patient with severe underlying disease 4.Patient with severe allergy disease
研究者
相似试验
已完成
1 期
Phase I study of peptide vaccination for patients with biliary tract cancerbiliary tract cancerJPRN-UMIN000003207Tokyo Women's Medical University9
已完成
1 期
Phase I study of peptide vaccination for patients with unresectable pancreatic cancerPancreatic cancerJPRN-UMIN000004337Tokyo Women's Medical University9
已完成
1 期
Phase II study of peptide vaccination for patients with metastatic lung or gastro-intestinal tract cancerslung cancer, pharyngeal cancer, gastric cancer, jejunal cancer, ileal cancer, pancreas cancer, biliary tract cancer, soft tissue sarcomaJPRN-UMIN000002857Tohoku University Hospital14
已完成
1 期
Phase I / II clinical trial of peptide vaccination therapy for unresectable / recurrent pancreatic cancer to be refractory to chemotherapy by using new tumor antigen KIF20A and A2402 restrictive epitope peptide of the VEGFR1 origin related gene of tumor vascularizatiopancreatic cancerJPRN-UMIN000002022Department of Gastroenterology, Juntendo University School of Medicine36
已完成
1 期
Phase I / II clinical trial of peptide vaccination therapy for unresectable / recurrent gastric cancer to be refractory to chemotherapy by using new tumor antigen URLC10 and A2402 restrictive epitope peptide of the VEGFR1 origin related gene of tumor vascularizatiogastric cancerJPRN-UMIN000002409Department of Gastroenterology, Juntendo University School of Medicine36